Free shipping on all orders over $ 500

Gevokizumab

Cat. No. M24552

All AbMole products are for research use only, cannot be used for human consumption.

Gevokizumab Structure

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Gevokizumab is a potent anti-IL-1β antibody, negatively modulates IL-1β signaling through an allosteric mechanism. Gevokizumab selectively decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor instead of IL-1 counter-regulatory decoy receptor (IL-1 receptor type II).

Chemical Information
CAS Number 1129435-60-4
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Dennis D Arnold, et al. Front Immunol. Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders

[2] Veronique Promelle, et al. J Clin Med. Rheumatoid Arthritis Associated Episcleritis and Scleritis: An Update on Treatment Perspectives

[3] Wen-Ming Wang, et al. Expert Opin Drug Saf. Biologics in the treatment of pustular psoriasis

[4] Kalliopi Pafili, et al. Expert Opin Investig Drugs. Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?

Related IL Receptor/Related Products
Reslizumab

Reslizumab (Sch 55700) is a humanized monoclonal antibody targeting human interleukin 5 (IL-5) for the study of eosinophilic asthma. Reslizumab effectively blocks il-5 function. Reslizumab inhibited IL-5-dependent cell proliferation with an IC50 of about 91.1 pM.

Montelukast sodium

Montelukast sodium selectively antagonizes leukotriene D 4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1.

VGX-1027

VGX-1027 is an orally active immunomodulator.

Diacerein

Diacerin is an inhibitor of pro-inflammatory cytokine Interleukin-1B (IL-1B) production, prescribed for osteoarthritis and chronic inflammatory arthritis.

SC144

SC144 is the first oral active GP130 (IL6-beta) inhibitor. SC144 binds gp130, induces gp130 phosphorylation (S782) and deglycosylation, eliminates Stat3 phosphorylation and nuclear translocation, and further inhibits downstream target gene expression. SC144 inhibited signal transduction induced by GP130 ligand. SC144 induces apoptosis of human ovarian cancer cells.

  Catalog
Abmole Inhibitor Catalog




Keywords: Gevokizumab supplier, IL Receptor/Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.